Alan Holmer - Jan 26, 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Alan Holmer
Stock symbol
CRBP
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 06:07 PM
Previous filing
May 22, 2023
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock Options Exercise $3.13K +629 +83.87% $4.97 1.38K Jan 26, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Options to purchase common stock Options Exercise -$3.13K -629 -100% $4.97 0 Jan 26, 2024 Common stock 629 $4.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option vested in equal monthly installments over a period of 12 months commencing on February 28, 2014.